| MRI to predict upstaging of DCIS to invasive cancer at the time of surgery JK Olapo, SH Javid, A Kazerouni, D Hippe, A Guo, M Hirano, D Biswas, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S83-S84, 2024 | | 2024 |
| Clinical proteomics for solid organ tissues WS Phipps, MR Kilgore, JJ Kennedy, JR Whiteaker, AN Hoofnagle, ... Molecular & Cellular Proteomics 22 (11), 2023 | 3 | 2023 |
| Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing IV Rodriguez, S Strickland, D Wells, E Manhardt, EQ Konnick, R Garcia, ... JCO Precision Oncology 7, e2300033, 2023 | 1 | 2023 |
| Erratum: Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts (Cancer Cell (2022) 40 (12 … SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... Cancer cell 41 (7), 1381, 2023 | | 2023 |
| Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... Cancer cell 41 (7), 1381, 2023 | | 2023 |
| Comparison of conventional clinical models and a multigene assay to assess DCIS risk in a prospective single center study. L Wairiri, JN Kim, SC Partridge, SH Javid, MR Kilgore, D Biswas, ... Journal of Clinical Oncology 41 (16_suppl), e12578-e12578, 2023 | | 2023 |
| Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making EJ Austin, MR Kilgore, CW Ko, EU Parker, R Alvarez, LK Koch, ... Cancer Causes & Control 34 (4), 399-406, 2023 | 2 | 2023 |
| Abstract P1-07-02: Using clinical characteristics and molecular markers to predict the risk of subsequent ipsilateral breast events after excision of DCIS Y Liu, SH Strand, L King, B Harmon, FJ Couch, K Gallagher, M Kilgore, ... Cancer Research 83 (5_Supplement), P1-07-02-P1-07-02, 2023 | | 2023 |
| Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. SH Strand, KE Houlahan, V Branch, T Lynch, B Harmon, F Couch, ... bioRxiv, 2023.09. 28.560000, 2023 | | 2023 |
| Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... Cancer cell 40 (12), 1521-1536. e7, 2022 | 24 | 2022 |
| DCIS AI-TIL: Ductal Carcinoma In Situ Tumour Infiltrating Lymphocyte Scoring Using Artificial Intelligence YB Hagos, F Sobhani, SP Castillo, AH Hall, K AbdulJabbar, R Salgado, ... MICCAI Workshop on Medical Image Assisted Blomarkers' Discovery, 164-175, 2022 | | 2022 |
| Error reduction and diagnostic concordance in breast pathology TI Miller, MR Flanagan, KP Lowry, MR Kilgore Surgical Pathology Clinics 15 (1), 1-13, 2022 | 1 | 2022 |
| Abstract GS4-07: The Breast PreCancer Atlas DCIS genomic signatures define biology and correlate with clinical outcomes: An analysis of TBCRC 038 and RAHBT cohorts SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... Cancer Research 82 (4_Supplement), GS4-07-GS4-07, 2022 | | 2022 |
| Adoption of universal next generation sequencing for lynch syndrome screening in endometrial cancer I Rodriguez, S Strickland, D Wells, E Manhardt, E Konnick, R Garcia, ... Gynecologic Oncology 164 (1), 4-5, 2022 | | 2022 |
| Formalized radiologic-pathologic curriculum in breast imaging for breast imaging fellows and residents: how we do it SM Zelasko, B O’Steen, E Parker, M Kilgore, JR Scheel Current Breast Cancer Reports 13, 405-413, 2021 | 1 | 2021 |
| Radiologic and Pathologic Correlation for Benign Breast Processes H Cheung, EU Parker, M Yu, MR Kilgore, DL Lam Current Breast Cancer Reports 13 (4), 381-397, 2021 | | 2021 |
| Intrapleural silicone granuloma mimicking pleural malignancy K Vo, M Kilgore, J Scheel Radiology Case Reports 16 (12), 3824-3828, 2021 | 1 | 2021 |
| Adoption of universal next generation sequencing for Lynch syndrome screening in endometrial cancer I Rodriguez, D Wells, E Manhardt, E Konnick, R Garcia, E Swisher, ... Gynecologic Oncology 162, S84-S85, 2021 | | 2021 |
| Quantification of human epidermal growth factor receptor 2 by immunopeptide enrichment and targeted mass spectrometry in formalin-fixed paraffin-embedded and frozen breast … JJ Kennedy, JR Whiteaker, LC Kennedy, DE Bosch, ML Lerch, ... Clinical chemistry 67 (7), 1008-1018, 2021 | 30 | 2021 |
| DCIS genomic signatures define biology and clinical outcome: Human Tumor Atlas Network (HTAN) analysis of TBCRC 038 and RAHBT cohorts SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... | 2 | 2021 |
Elizabeth SwisherVerified email at uw.edu
